The small, 10-color Navios EX integrates the company's award-winning CytoFLEX research flow cytometer's innovative optics and laser technology. The Navios EX uses Tetra reagents to offer accurate, high-complexity immunophenotyping. Food and Drug Administration approval for their Navios EX flow cytometer, a clinical flow cytometry device that can be used in the clinical laboratory in the U.S. For instance, in August 2017, Beckman Coulter, Inc. Major market players are concentrating on the launch and approval of new products, which is expected to drive market growth during the forecast period. However, the global flow cytometry market is expected to be hindered by a lack of technical expertise for handling and administering testing services for plasmid DNA and viral vector. Growing demands for flow cytometry in hospitals and medical centers for efficient disease detection and monitoring are expected to drive the global flow cytometry market growth. The global flow cytometry market is expected to grow due to the rising use of flow cytometry in diagnostic procedures such as the CD4 test for HIV.Ĭompetitive Landscape: Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc., and Danaher Corporation.ĭuring the forecast period, the global flow cytometry market growth is expected to be propelled by new applications of flow cytometers in marine cell biology, proteomics, and cytogenomics. Researchers can use this approach to obtain highly detailed information on individual cells. Furthermore, advances in flow cytometry technology, such as the use of more robust photodetectors and novel laser emitters, the use of LED lamps as emitters, and modifications in an analytical capacity, are expected to propel the global flow cytometry market growth during the forecast period. Flow cytometers are used in a variety of research areas, such as hematology, cytology, microbiology, and immunology. The CytoFLEX SRT joins the CytoFLEX, CytoFLEX S, and CytoFLEX LX benchtop Flow Cytometers by Beckman Coulter Life Sciences.Flow cytometry is a laser-based procedure that can be used for biomarker detection, cell counting, sorting, and protein engineering. Pavel Lorenzo, Senior Engineer in Service and Support, Beckman Coulter Life Sciences said, "In this project we have emphasised reliability and serviceability while also building in special tools to allow us to quickly isolate a problem and get to a solution."
#BECKMAN COULTER CYTOFLEX FREE#
As social distancing continues, the ability to free up lab staff while requiring minimal training to use the instrument is further applauded by users.
#BECKMAN COULTER CYTOFLEX SOFTWARE#
First-time users praise the hassle-free experience and immediate convenience.ĬytExpert SRT software increases automation while requiring less supervision for both routine and complex samples. The CytoFLEX SRT is Beckman Coulter’s first benchtop cell sorter and offers up to four lasers and 17 detection channels to help accelerate answers in genomics and immunophenotyping workflows. It now boasts new technologies to automate and simplify sort setup and stream maintenance, bringing the power of single-cell analysis to more laboratories.ĭr Mario Koksch, Vice President and General Manager, Flow Cytometry business unit, Beckman Coulter Life Sciences said, "We take an individual approach to each lab, which is why we designed the CytoFLEX SRT to have the option for additional lasers and detectors activated when those customer needs arise." The software experience will be very familiar, further increasing the ease-of-use right out of the box. This new addition to the CytoFLEX platform builds on the principles of the CytoFLEX, which make multicolour applications accessible. Beckman Coulter Life Sciences has announced the launch of its highly anticipated CytoFLEX SRT Benchtop Sorter- the CytoFLEX that sorts, and features expanded laser and colour options for use in labs of all sizes.